Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL911 (Ambien, Sanval, Zolpidem, Zolpidem civ) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor γ2 subunit/GABA A receptor alpha-1/beta-1/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111392] [GtoPdb: 404, 410, 414] [UniProtKB: P14867, P18505, P18507] | ||||||||
ChEMBL | Displacement of [3H]Flumazenil from human GABA-Aalpha1 receptor plus beta-2-gamma-2 expressed in HEK293 cells | B | 7.28 | pKi | 53 | nM | Ki | J Med Chem (2006) 49: 2526-2533 [PMID:16610795] |
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α1β3γ2. | - | 7.68 | pKi | 20.7 | nM | Ki |
Eur J Pharmacol (1995) 291: 301-9 [PMID:8719414]; Eur J Pharmacol (1996) 304: 155-62 [PMID:8813598]; Pharmacol Rev (2018) 70: 836-878 [PMID:30275042] |
GABAA receptor α1 subunit/GABAA receptor γ2 subunit/GABAA receptor β2 subunit/GABA-A receptor; alpha-1/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2095172] [GtoPdb: 404, 414, 411] [UniProtKB: P14867, P18507, P47870] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α1β3γ2. | - | 7.68 | pKi | 20.7 | nM | Ki |
Eur J Pharmacol (1995) 291: 301-9 [PMID:8719414]; Eur J Pharmacol (1996) 304: 155-62 [PMID:8813598]; Pharmacol Rev (2018) 70: 836-878 [PMID:30275042] |
ChEMBL | Inhibition of [3H]flumazenil binding to recombinant GABA-A receptor alpha-1-beta-2-gamma-2 subunits | B | 5 | pIC50 | >=10000 | nM | IC50 | Bioorg Med Chem Lett (1997) 7: 2277-2282 |
ChEMBL | Inhibition of [3H]flumazenil binding to recombinant GABA-A receptor alpha-1-beta-2-gamma-2 subunits | B | 7.33 | pIC50 | 46.3 | nM | IC50 | Bioorg Med Chem Lett (1997) 7: 2277-2282 |
ChEMBL | Positive allosteric modulation of human recombinant GABA-A receptor alpha1beta2gamma2 expressed in HEK293 cells assessed as potentiation of of GABA induced chloride currents treated every 60 secs measured for 7 secs by electrophysiological method | B | 6.62 | pEC50 | 240 | nM | EC50 | Eur J Med Chem (2016) 124: 456-467 [PMID:27598234] |
GABAA receptor γ2 subunit/GABAA receptor α1 subunit/GABAA receptor β2 subunit/GABA-A receptor; alpha-1/beta-2/gamma-2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2095167] [GtoPdb: 414, 404, 411] [UniProtKB: P18508, P62813, P63138] | ||||||||
ChEMBL | Binding affinity for mutant rat GABA-A receptor alpha-1-(arg)-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Displacement of [3H]flumazenil from rat GABA-A alpha-1-beta-2-gamma-2 receptor expressed in HEK293 cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2009) 52: 3723-3734 [PMID:19469479] |
ChEMBL | Displacement of [3H]flumazenil from rat GABA-A Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2 expressed in HEK293 cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2005) 48: 2936-2943 [PMID:15828832] |
ChEMBL | Displacement of [3H]flumazenil from rat GABA-Aalpha1 receptor plus beta-2-gamma-2 in HEK293 cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2006) 49: 2489-2495 [PMID:16610792] |
ChEMBL | Displacement of [3H]flumazenil from rat GABAA alpha-1-beta-2-gamma-2 expressed in HEK293 cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2007) 50: 1627-1634 [PMID:17335185] |
ChEMBL | Inhibition of [3H]flumazenil specific binding at rat GABA-A alpha-1-beta-2-gamma-2 receptor subunits expressed in HEK293 cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2001) 44: 2286-2297 [PMID:11428922] |
ChEMBL | Displacement of [3H]Ro-151788 from rat GABA-A receptor alpha-1-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 7.57 | pKi | 26.7 | nM | Ki | J Med Chem (2002) 45: 5710-5720 [PMID:12477354] |
ChEMBL | Binding affinity for recombinant rat GABA-A receptor alpha-1-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 7.57 | pKi | 26.7 | nM | Ki | J Med Chem (2003) 46: 310-313 [PMID:12519068] |
ChEMBL | Binding affinity for rat GABA-A receptor alpha-1-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 7.72 | pKi | 19 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
GABAA receptor α1 subunit/GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABA-A receptor; alpha-1/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094121] [GtoPdb: 404, 414, 412] [UniProtKB: P14867, P18507, P28472] | ||||||||
ChEMBL | Binding affinity towards human alpha-1-beta-3-gamma-2 GABA-A receptor using [3H]Ro-151788 expressed in L(tk-) cells | B | 7.28 | pKi | 52.1 | nM | Ki | J Med Chem (2004) 47: 3642-3657 [PMID:15214791] |
ChEMBL | Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-1-beta-3-gamma-2 subtype expressed in L (tk-) cells | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2005) 48: 1367-1383 [PMID:15743180] |
ChEMBL | Displacement of [3H]Ro 15-1788 from human recombinant GABAA alpha-1-beta-3-gamma-2 receptor expressed in L(tk-) cells | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2005) 48: 7089-7092 [PMID:16279764] |
ChEMBL | Binding affinity for human GABA-A receptor alpha-4-beta-3-gamma-2 subunits in L(tk-) cells | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2004) 47: 1807-1822 [PMID:15027873] |
ChEMBL | Binding affinity measured using LtK- cell membranes expressing GABA alpha-1-beta-3-gamma-2 receptor | B | 7.57 | pKi | 26.7 | nM | Ki | J Med Chem (1998) 41: 2537-2552 [PMID:9651158] |
ChEMBL | Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-1-beta-3-gamma-2 | B | 7.57 | pKi | 26.7 | nM | Ki | J Med Chem (2000) 43: 71-95 [PMID:10633039] |
ChEMBL | Displacement of [3H]flunitrazepam from human recombinant GABAA alpha-1-beta-3-gamma-2 receptor expressed in HEK cells by liquid scintillation counting | B | 7.57 | pKi | 26.7 | nM | Ki | Bioorg Med Chem (2010) 18: 7548-7564 [PMID:20888240] |
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α1β3γ2. | - | 7.68 | pKi | 20.7 | nM | Ki |
Eur J Pharmacol (1995) 291: 301-9 [PMID:8719414]; Eur J Pharmacol (1996) 304: 155-62 [PMID:8813598]; Pharmacol Rev (2018) 70: 836-878 [PMID:30275042] |
GABAA receptor γ2 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-2/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111413] [GtoPdb: 414, 405, 411] [UniProtKB: P18507, P47869, P47870] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α2β1γ2. | - | 6.12 | pKi | 760.6 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-2-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 6.39 | pKi | 408 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
ChEMBL | Potentiation of GABA-evoked Cl- currents in Xenopus oocytes expressing human alpha-2-beta-2-gamma-2 subunits | F | 6.74 | pEC50 | 180 | nM | EC50 | J Med Chem (1997) 40: 3109-3118 [PMID:9301675] |
GABAA receptor γ2 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-2/beta-2/gamma-2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111327] [GtoPdb: 414, 405, 411] [UniProtKB: P18508, P23576, P63138] | ||||||||
ChEMBL | Displacement of [3H]flumazenil from rat GABA-A Gamma-aminobutyric acid A receptor alpha-2-beta-2-gamma-2 expressed in HEK293 cells | B | 6.12 | pKi | 765 | nM | Ki | J Med Chem (2005) 48: 2936-2943 [PMID:15828832] |
ChEMBL | Displacement of [3H]flumazenil from rat GABA-Aalpha2 receptor plus beta-2-gamma-2 in HEK293 cells | B | 6.12 | pKi | 765 | nM | Ki | J Med Chem (2006) 49: 2489-2495 [PMID:16610792] |
ChEMBL | Displacement of [3H]flumazenil from rat GABAA alpha-2-beta-2-gamma-2 expressed in HEK293 cells | B | 6.12 | pKi | 765 | nM | Ki | J Med Chem (2007) 50: 1627-1634 [PMID:17335185] |
ChEMBL | Binding affinity for recombinant rat GABA-A receptor alpha-2-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 6.81 | pKi | 156 | nM | Ki | J Med Chem (2003) 46: 310-313 [PMID:12519068] |
GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α2 subunit/GABA-A receptor; alpha-2/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094130] [GtoPdb: 414, 412, 405] [UniProtKB: P18507, P28472, P47869] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α2β1γ2. | - | 6.12 | pKi | 760.6 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Binding affinity towards human gamma-aminobutyric-acid A receptor alpha-2-beta-3-gamma-2 using [3H]Ro-151788 expressed in L(tk-) cells | B | 6.59 | pKi | 255.1 | nM | Ki | J Med Chem (2004) 47: 3642-3657 [PMID:15214791] |
ChEMBL | Binding affinity for human GABA-A receptor alpha-2-beta-3-gamma-2 subunits in L(tk-) cells | B | 6.8 | pKi | 160 | nM | Ki | J Med Chem (2004) 47: 1807-1822 [PMID:15027873] |
ChEMBL | Displacement of [3H]Ro 15-1788 from human recombinant GABAA alpha-2-beta-3-gamma-2 receptor expressed in L(tk-) cells | B | 6.8 | pKi | 160 | nM | Ki | J Med Chem (2005) 48: 7089-7092 [PMID:16279764] |
ChEMBL | Binding affinity measured using LtK- cell membranes expressing GABA alpha-2-beta-3-gamma-2 receptor | B | 6.81 | pKi | 156 | nM | Ki | J Med Chem (1998) 41: 2537-2552 [PMID:9651158] |
ChEMBL | Binding affinity to human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-2-beta-3-gamma-2 | B | 6.81 | pKi | 156 | nM | Ki | J Med Chem (2000) 43: 71-95 [PMID:10633039] |
ChEMBL | Displacement of [3H]flunitrazepam from human recombinant GABAA alpha-2-beta-3-gamma-2 receptor expressed in HEK cells by liquid scintillation counting | B | 6.81 | pKi | 156 | nM | Ki | Bioorg Med Chem (2010) 18: 7548-7564 [PMID:20888240] |
ChEMBL | Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 subtype expressed in L (tk-) cells | B | 6.99 | pKi | 103 | nM | Ki | J Med Chem (2005) 48: 1367-1383 [PMID:15743180] |
GABAA receptor γ2 subunit/GABAA receptor α3 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-3/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111339] [GtoPdb: 414, 406, 411] [UniProtKB: P18507, P34903, P47870] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α3β1γ2. | - | 5.67 | pKi | 2149.5 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Displacement of [3H]Flumazenil from human GABA-Aalpha3 receptor plus beta-2-gamma-2 expressed in HEK293 cells | B | 5.73 | pKi | 1850 | nM | Ki | J Med Chem (2006) 49: 2526-2533 [PMID:16610795] |
ChEMBL | Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-3-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 6.01 | pKi | 975 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
GABAA receptor γ2 subunit/GABAA receptor α3 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-3/beta-2/gamma-2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111343] [GtoPdb: 414, 406, 411] [UniProtKB: P18508, P20236, P63138] | ||||||||
ChEMBL | Inhibition of [3H]-flumazenil binding to rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 6.12 | pKi | 765 | nM | Ki | J Med Chem (2001) 44: 2286-2297 [PMID:11428922] |
ChEMBL | Binding affinity for rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 6.4 | pKi | 400 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Displacement of [3H]Ro-151788 from rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 6.42 | pKi | 383 | nM | Ki | J Med Chem (2002) 45: 5710-5720 [PMID:12477354] |
ChEMBL | Binding affinity for recombinant rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 6.42 | pKi | 383 | nM | Ki | J Med Chem (2003) 46: 310-313 [PMID:12519068] |
GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α3 subunit/GABA-A receptor; alpha-3/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094120] [GtoPdb: 414, 412, 406] [UniProtKB: P18507, P28472, P34903] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α3β1γ2. | - | 5.67 | pKi | 2149.5 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Binding affinity towards human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2 using [3H]Ro-151788 expressed in L(tk-) cells | B | 6.22 | pKi | 608.5 | nM | Ki | J Med Chem (2004) 47: 3642-3657 [PMID:15214791] |
ChEMBL | Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-3-beta-3-gamma-2 | B | 6.42 | pKi | 383 | nM | Ki | J Med Chem (2000) 43: 71-95 [PMID:10633039] |
ChEMBL | Binding affinity measured using LtK- cell membranes expressing GABA alpha-3-beta-3-gamma-2 receptor | B | 6.42 | pKi | 383 | nM | Ki | J Med Chem (1998) 41: 2537-2552 [PMID:9651158] |
ChEMBL | Displacement of [3H]flunitrazepam from human recombinant GABAA alpha-3-beta-3-gamma-2 receptor expressed in HEK cells by liquid scintillation counting | B | 6.42 | pKi | 383 | nM | Ki | Bioorg Med Chem (2010) 18: 7548-7564 [PMID:20888240] |
ChEMBL | Displacement of [3H]Ro 15-1788 from human recombinant GABAA alpha-3-beta-3-gamma-2 receptor expressed in L(tk-) cells | B | 6.42 | pKi | 380 | nM | Ki | J Med Chem (2005) 48: 7089-7092 [PMID:16279764] |
ChEMBL | Binding affinity for human GABA-A receptor alpha-3-beta-3-gamma-2 subunits in L(tk-) cells | B | 6.42 | pKi | 380 | nM | Ki | J Med Chem (2004) 47: 1807-1822 [PMID:15027873] |
ChEMBL | Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2 subtype expressed in L (tk-) cells | B | 6.61 | pKi | 246 | nM | Ki | J Med Chem (2005) 48: 1367-1383 [PMID:15743180] |
GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor β3 subunit/GABA A receptor alpha-5/beta-3/gamma-2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111374] [GtoPdb: 414, 408, 412] [UniProtKB: P18508, P19969, P63079] | ||||||||
ChEMBL | Binding affinity for recombinant rat GABA-A receptor alpha-5-beta-3-gamma-2 subunits expressed in HEK 293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2003) 46: 310-313 [PMID:12519068] |
ChEMBL | Displacement of [3H]flumazenil from rat GABA-A alpha-5-beta-3-gamma-2 receptor expressed in HEK293 cells | B | 7.46 | pKi | 35 | nM | Ki | J Med Chem (2009) 52: 3723-3734 [PMID:19469479] |
GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABA-A receptor; alpha-5/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094122] [GtoPdb: 414, 412, 408] [UniProtKB: P18507, P28472, P31644] | ||||||||
ChEMBL | Binding affinity for human GABA-A receptor alpha-5-beta-3-gamma-2 subunits in L(tk-) cells | B | 4.82 | pKi | >15000 | nM | Ki | J Med Chem (2004) 47: 1807-1822 [PMID:15027873] |
ChEMBL | Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-5-beta-3-gamma-2 | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2000) 43: 71-95 [PMID:10633039] |
ChEMBL | Binding affinity towards human alpha-5-beta-3-gamma-2 GABA-A receptor using [3H]Ro-151788 expressed in L(tk-) cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2004) 47: 3642-3657 [PMID:15214791] |
ChEMBL | Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-5-beta-3-gamma-2 | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1998) 41: 2537-2552 [PMID:9651158] |
ChEMBL | Displacement of [3H]flunitrazepam from human recombinant GABAA alpha-5-beta-3-gamma-2 receptor expressed in HEK cells by liquid scintillation counting | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem (2010) 18: 7548-7564 [PMID:20888240] |
ChEMBL | Inhibition of [3H]Ro-151788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-5-beta-3-gamma-2 subtype expressed in L (tk-) cells | B | 5.48 | pKi | >3333 | nM | Ki | J Med Chem (2005) 48: 1367-1383 [PMID:15743180] |
GABAA receptor γ2 subunit/GABAA receptor β2 subunit/GABAA receptor α6 subunit/GABA A receptor alpha-6/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111370] [GtoPdb: 414, 411, 409] [UniProtKB: P18507, P47870, Q16445] | ||||||||
ChEMBL | Displacement of [3H]Ro-154513 from benzodiazepine binding site of GABAA alpha-6-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 4.82 | pKi | >15000 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
GABAA receptor γ2 subunit/GABAA receptor α6 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-6/beta-2/gamma-2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111365] [GtoPdb: 414, 409, 411] [UniProtKB: P18508, P30191, P63138] | ||||||||
ChEMBL | Binding affinity for rat GABA-A receptor alpha-6-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Binding affinity for mutant rat GABA-A receptor alpha-6-(his)-beta-2-gamma-2 subunits expressed in HEK293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr)beta2gamma2 subunits expressed in HEK293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr,gly,val)beta2gamma2 subunits expressed in HEK293 cells | B | 5.85 | pKi | 1400 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
ChEMBL | Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr,gly)beta2gamma2 subunits expressed in HEK293 cells | B | 6.01 | pKi | 980 | nM | Ki | J Med Chem (1994) 37: 4576-4580 [PMID:7799410] |
GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α6 subunit/GABA-A receptor; alpha-6/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2095190] [GtoPdb: 414, 412, 409] [UniProtKB: P18507, P28472, Q16445] | ||||||||
ChEMBL | Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-6-beta-3-gamma-2 | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2000) 43: 71-95 [PMID:10633039] |
ChEMBL | Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-6-beta-3-gamma-2 | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (1998) 41: 2537-2552 [PMID:9651158] |
ChEMBL | Displacement of [3H]flunitrazepam from human recombinant GABAA alpha-6-beta-3-gamma-2 receptor expressed in HEK cells by liquid scintillation counting | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem (2010) 18: 7548-7564 [PMID:20888240] |
GABAA receptor π subunit/GABAA receptor β1 subunit/GABAA receptor δ subunit/GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor γ1 subunit/GABAA receptor α2 subunit/GABAA receptor α4 subunit/GABAA receptor γ3 subunit/GABAA receptor α6 subunit/GABAA receptor α1 subunit/GABAA receptor β3 subunit/GABAA receptor β2 subunit/GABAA receptor ε subunit in Human [GtoPdb: 419, 410, 416, 414, 408, 406, 413, 405, 407, 415, 409, 404, 412, 411, 417] [UniProtKB: O00591, P18505, O14764, P18507, P31644, P34903, Q8N1C3, P47869, P48169, Q99928, Q16445, P14867, P28472, P47870, P78334] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α3β1γ2. | - | 5.67 | pKi | 2149.5 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α2β1γ2. | - | 6.12 | pKi | 760.6 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α1β3γ2. | - | 7.68 | pKi | 20.7 | nM | Ki |
Eur J Pharmacol (1995) 291: 301-9 [PMID:8719414]; Eur J Pharmacol (1996) 304: 155-62 [PMID:8813598]; Pharmacol Rev (2018) 70: 836-878 [PMID:30275042] |
GABAA receptor π subunit/GABAA receptor β1 subunit/GABAA receptor δ subunit/GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor γ1 subunit/GABAA receptor α2 subunit/GABAA receptor α4 subunit/GABAA receptor γ3 subunit/GABAA receptor α6 subunit/GABAA receptor α1 subunit/GABAA receptor β3 subunit/GABAA receptor β2 subunit/GABAA receptor ε subunit/GABA-A receptor; anion channel in Rat (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL1907607] [GtoPdb: 419, 410, 416, 414, 408, 406, 413, 405, 407, 415, 409, 404, 412, 411, 417] [UniProtKB: O09028, P15431, P18506, P18508, P19969, P20236, P23574, P23576, P28471, P28473, P30191, P62813, P63079, P63138, Q91ZM7, Q9ES14] | ||||||||
ChEMBL | Binding affinity was determined by displacement of [3H]flumazenil from rat cortex homogenates | F | 7.32 | pKi | 48 | nM | Ki | J Med Chem (2002) 45: 5043-5051 [PMID:12408715] |
ChEMBL | Displacement of [3H]- flunitrazepam from rat GABA-A benzodiazepine receptor | B | 7.6 | pKi | 25 | nM | Ki | J Med Chem (1994) 37: 758-768 [PMID:8145225] |
ChEMBL | Displacement of [3H]flunitrazepam from rat brain GABA-A Benzodiazepine receptor | B | 7.32 | pIC50 | 48 | nM | IC50 | J Med Chem (1997) 40: 3109-3118 [PMID:9301675] |
GABAA receptor α1 subunit/GABA receptor alpha-1 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1962] [GtoPdb: 404] [UniProtKB: P14867] | ||||||||
ChEMBL | Displacement of [3H]Ro15-1788 from benzodiazepine binding site of GABAA alpha-1-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 7.21 | pKi | 61.9 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α1β3γ2. | - | 7.68 | pKi | 20.7 | nM | Ki |
Eur J Pharmacol (1995) 291: 301-9 [PMID:8719414]; Eur J Pharmacol (1996) 304: 155-62 [PMID:8813598]; Pharmacol Rev (2018) 70: 836-878 [PMID:30275042] |
ChEMBL | Inhibition of GABAA receptor alpha1 (unknown origin) | B | 7.7 | pKi | 20 | nM | Ki | Eur J Med Chem (2019) 181: 111569-111569 [PMID:31404862] |
ChEMBL | Inhibition of [3H]flumazenil binding to recombinant GABA-A receptor alpha-1 subunit in spinal cord | B | 6.89 | pIC50 | 130 | nM | IC50 | Bioorg Med Chem Lett (1997) 7: 2277-2282 |
ChEMBL | Inhibition of [3H]flumazenil binding to recombinant GABA-A receptor alpha-1 subunit in cerebellum | B | 7.85 | pIC50 | 14 | nM | IC50 | Bioorg Med Chem Lett (1997) 7: 2277-2282 |
ChEMBL | Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 1 | B | 6.7 | pEC50 | 198 | nM | EC50 | J Med Chem (2002) 45: 5043-5051 [PMID:12408715] |
ChEMBL | Activity at rat wild type GABAA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as GABA-elicited response by two electrode voltage clamp method relative to control | B | 6.72 | pEC50 | 191 | nM | EC50 | J Biol Chem (2007) 282: 26316-26325 [PMID:17626010] |
GABAA receptor α1 subunit/GABA receptor alpha-1 subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL343] [GtoPdb: 404] [UniProtKB: P62813] | ||||||||
ChEMBL | Displacement of [3H]RO15-1788 from recombinant rat GABAalpha1 receptor expressed in HEK293 cells after 1 hr | B | 7.57 | pKi | 26.7 | nM | Ki | Eur J Med Chem (2017) 126: 298-352 [PMID:27894044] |
GABAA receptor α2 subunit/GABA receptor alpha-2 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4956] [GtoPdb: 405] [UniProtKB: P47869] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α2β1γ2. | - | 6.12 | pKi | 760.6 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2 | B | 6.13 | pEC50 | 737 | nM | EC50 | J Med Chem (2002) 45: 5043-5051 [PMID:12408715] |
GABAA receptor α2 subunit/GABA receptor alpha-2 subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL341] [GtoPdb: 405] [UniProtKB: P23576] | ||||||||
ChEMBL | Displacement of [3H]flumazenil from rat GABA-A alpha-2-beta-2-gamma-2 receptor expressed in HEK293 cells | B | 6.12 | pKi | 765 | nM | Ki | J Med Chem (2009) 52: 3723-3734 [PMID:19469479] |
ChEMBL | Displacement of [3H]RO15-1788 from recombinant rat GABAalpha2 receptor expressed in HEK293 cells after 1 hr | B | 6.81 | pKi | 156 | nM | Ki | Eur J Med Chem (2017) 126: 298-352 [PMID:27894044] |
GABAA receptor α3 subunit/GABA receptor alpha-3 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3026] [GtoPdb: 406] [UniProtKB: P34903] | ||||||||
GtoPdb | Assay using recombinant GABAA channels with subunit composition; α3β1γ2. | - | 5.67 | pKi | 2149.5 | nM | Ki | Mol Pharmacol (1993) 43: 970-5 [PMID:8391122] |
ChEMBL | Inhibition of GABAA receptor alpha3 (unknown origin) | B | 6.4 | pKi | 400 | nM | Ki | Eur J Med Chem (2019) 181: 111569-111569 [PMID:31404862] |
ChEMBL | Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 3 | B | 5.52 | pEC50 | >3000 | nM | EC50 | J Med Chem (2002) 45: 5043-5051 [PMID:12408715] |
GABAA receptor α3 subunit/GABA receptor alpha-3 subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL328] [GtoPdb: 406] [UniProtKB: P20236] | ||||||||
ChEMBL | Displacement of [3H]RO15-1788 from recombinant rat GABAalpha3 receptor expressed in HEK293 cells after 1 hr | B | 6.42 | pKi | 383 | nM | Ki | Eur J Med Chem (2017) 126: 298-352 [PMID:27894044] |
GABAA receptor α4 subunit/GABA receptor alpha-4 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2472] [GtoPdb: 407] [UniProtKB: P48169] | ||||||||
ChEMBL | Displacement of [3H]Ro-154513 from benzodiazepine binding site of GABAA alpha-4-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 4.82 | pKi | >15000 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
GABAA receptor α5 subunit/GABA receptor alpha-5 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5112] [GtoPdb: 408] [UniProtKB: P31644] | ||||||||
ChEMBL | Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-5-beta-2-gamma-2 receptor expressed in HEK293T cells | B | 4.82 | pKi | >15000 | nM | Ki | J Med Chem (2008) 51: 7243-7252 [PMID:18973287] |
ChEMBL | Effective concentration against Gamma-aminobutyric acid A receptor, alpha 5 | B | 5.52 | pEC50 | >3000 | nM | EC50 | J Med Chem (2002) 45: 5043-5051 [PMID:12408715] |
GABAA receptor α5 subunit/GABA receptor alpha-5 subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL300] [GtoPdb: 408] [UniProtKB: P19969] | ||||||||
ChEMBL | Displacement of [3H]RO15-1788 from recombinant rat GABAalpha5 receptor expressed in HEK293 cells after 1 hr | B | 5 | pKi | >10000 | nM | Ki | Eur J Med Chem (2017) 126: 298-352 [PMID:27894044] |
Translocator protein/Peripheral-type benzodiazepine receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4552] [GtoPdb: 2879] [UniProtKB: P16257] | ||||||||
ChEMBL | Displacement of Ro 5-4864 from peripheral (renal cell) Benzodiazepine receptor | B | 5.33 | pIC50 | 4700 | nM | IC50 | J Med Chem (1997) 40: 3109-3118 [PMID:9301675] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]